Filtered By:
Specialty: Opthalmology
Drug: Ranibizumab Injection
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Modulation of Bevacizumab-Induced Toxicity for Cultured Human Corneal Fibroblasts Cornea
Conclusions.
This study determined the cellular toxicity of bevacizumab and its modulation with bFGF or NGF. Cotreatment with bFGF or NGF with bevacizumab reduced cellular damage without interfering with the original antiangiogenic function. Some components of serum have a protective effect on bevacizumab-induced corneal epithelial change.
Source: Investigative Ophthalmology - June 6, 2013 Category: Opthalmology Authors: Kim, E. K., Kang, S. W., Kim, J. Y., Min, K., Kim, T.-i. Tags: Cornea Source Type: research
